| Alicia Roston, MD | |
|
1883 Mill St, Wailuku, HI 96793-1236 | |
| (808) 242-8765 | |
| Not Available |
| Full Name | Alicia Roston |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Location | 1883 Mill St, Wailuku, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700380029 | NPI | - | NPPES |
| Entity Name | Maui Urology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073179669 PECOS PAC ID: 9739413741 Enrollment ID: O20190625003413 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has received notice from The NASDAQ Stock Market confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.
As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.
Researchers have identified a gene mutation that causes developmental delay, intellectual disability, behavioral abnormalities and musculoskeletal problems in children. The newly diagnosed condition, called NKAP-related syndrome, arises from mutations in the NKAP gene, which plays a key role in human development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Roston, MD 1883 Mill St, Wailuku, HI 96793-1236 Ph: (808) 242-8765 | Alicia Roston, MD 1883 Mill St, Wailuku, HI 96793-1236 Ph: (808) 242-8765 |
News Archive
Catalyst Pharmaceutical Partners, Inc. announced today that it has received notice from The NASDAQ Stock Market confirming that the Company has regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.
Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.
As the SARS-CoV-2 virus, or COVID-19 has unfurled its tentacles across the globe, the severe respiratory and pulmonary disorders associated with the infection have become well known.
Researchers have identified a gene mutation that causes developmental delay, intellectual disability, behavioral abnormalities and musculoskeletal problems in children. The newly diagnosed condition, called NKAP-related syndrome, arises from mutations in the NKAP gene, which plays a key role in human development.
› Verified 8 days ago
Soren N Carlsen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 71 Kanoa St Ste 201, Wailuku, HI 96793 Phone: 808-242-8765 Fax: 808-242-8769 | |
Benjamin T. Shurtleff, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000 | |
J. Glenn Haines, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1830 Wells St, Ste 101, Wailuku, HI 96793 Phone: 808-244-3200 Fax: 808-244-9793 | |
Todd H. Hoekstra, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 80 Mahalani St, Wailuku, HI 96793 Phone: 808-243-6000 |